These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


170 related items for PubMed ID: 20804750

  • 1. Isoforms of p38MAPK gamma and delta contribute to differentiation of human AML cells induced by 1,25-dihydroxyvitamin D₃.
    Zhang J, Harrison JS, Studzinski GP.
    Exp Cell Res; 2011 Jan 01; 317(1):117-30. PubMed ID: 20804750
    [Abstract] [Full Text] [Related]

  • 2. Oncoprotein Cot1 represses kinase suppressors of Ras1/2 and 1,25-dihydroxyvitamin D3-induced differentiation of human acute myeloid leukemia cells.
    Wang X, Studzinski GP.
    J Cell Physiol; 2011 May 01; 226(5):1232-40. PubMed ID: 20945381
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 1,25-Dihydroxyvitamin D3 induces monocytic differentiation of human myeloid leukemia cells by regulating C/EBPβ expression through MEF2C.
    Zheng R, Wang X, Studzinski GP.
    J Steroid Biochem Mol Biol; 2015 Apr 01; 148():132-7. PubMed ID: 25448741
    [Abstract] [Full Text] [Related]

  • 6. Retinoblastoma protein and CCAAT/enhancer-binding protein beta are required for 1,25-dihydroxyvitamin D3-induced monocytic differentiation of HL60 cells.
    Ji Y, Studzinski GP.
    Cancer Res; 2004 Jan 01; 64(1):370-7. PubMed ID: 14729647
    [Abstract] [Full Text] [Related]

  • 7. Differentiation-inducing potency of the seco-steroid JK-1624F2-2 can be increased by combination with an antioxidant and a p38MAPK inhibitor which upregulates the JNK pathway.
    Zhang J, Posner GH, Danilenko M, Studzinski GP.
    J Steroid Biochem Mol Biol; 2007 Jan 01; 105(1-5):140-9. PubMed ID: 17583492
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Jun N-terminal kinase pathway enhances signaling of monocytic differentiation of human leukemia cells induced by 1,25-dihydroxyvitamin D3.
    Wang Q, Wang X, Studzinski GP.
    J Cell Biochem; 2003 Aug 15; 89(6):1087-101. PubMed ID: 12898508
    [Abstract] [Full Text] [Related]

  • 10. 1,25-dihydroxyvitamin D3 enhances the apoptotic activity of MDM2 antagonist nutlin-3a in acute myeloid leukemia cells expressing wild-type p53.
    Thompson T, Andreeff M, Studzinski GP, Vassilev LT.
    Mol Cancer Ther; 2010 May 15; 9(5):1158-68. PubMed ID: 20406950
    [Abstract] [Full Text] [Related]

  • 11. The Nrf2 transcription factor is a positive regulator of myeloid differentiation of acute myeloid leukemia cells.
    Bobilev I, Novik V, Levi I, Shpilberg O, Levy J, Sharoni Y, Studzinski GP, Danilenko M.
    Cancer Biol Ther; 2011 Feb 01; 11(3):317-29. PubMed ID: 21099366
    [Abstract] [Full Text] [Related]

  • 12. Protein kinase C is not necessary for transforming growth factor beta-induced growth-arrest in leukemia cell lines.
    Manzel L, Macfarlane DE.
    Leuk Res; 1997 May 01; 21(5):403-10. PubMed ID: 9225067
    [Abstract] [Full Text] [Related]

  • 13. ERK5 pathway regulates transcription factors important for monocytic differentiation of human myeloid leukemia cells.
    Wang X, Pesakhov S, Harrison JS, Danilenko M, Studzinski GP.
    J Cell Physiol; 2014 Jul 01; 229(7):856-67. PubMed ID: 24264602
    [Abstract] [Full Text] [Related]

  • 14. Regulation of C/EBPbeta isoforms by MAPK pathways in HL60 cells induced to differentiate by 1,25-dihydroxyvitamin D3.
    Marcinkowska E, Garay E, Gocek E, Chrobak A, Wang X, Studzinski GP.
    Exp Cell Res; 2006 Jul 01; 312(11):2054-65. PubMed ID: 16624284
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of p38MAP kinase potentiates the JNK/SAPK pathway and AP-1 activity in monocytic but not in macrophage or granulocytic differentiation of HL60 cells.
    Wang X, Studzinski GP.
    J Cell Biochem; 2006 Jul 01; 82(1):68-77. PubMed ID: 11400164
    [Abstract] [Full Text] [Related]

  • 16. Raf-1 signaling is required for the later stages of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells but is not mediated by the MEK/ERK module.
    Wang X, Studzinski GP.
    J Cell Physiol; 2006 Nov 01; 209(2):253-60. PubMed ID: 16883571
    [Abstract] [Full Text] [Related]

  • 17. ERK 5/MAPK pathway has a major role in 1α,25-(OH)2 vitamin D3-induced terminal differentiation of myeloid leukemia cells.
    Wang X, Pesakhov S, Weng A, Kafka M, Gocek E, Nguyen M, Harrison JS, Danilenko M, Studzinski GP.
    J Steroid Biochem Mol Biol; 2014 Oct 01; 144 Pt A():223-7. PubMed ID: 24514755
    [Abstract] [Full Text] [Related]

  • 18. Expression of MAP3 kinase COT1 is up-regulated by 1,25-dihydroxyvitamin D3 in parallel with activated c-jun during differentiation of human myeloid leukemia cells.
    Wang X, Studzinski GP.
    J Steroid Biochem Mol Biol; 2010 Jul 01; 121(1-2):395-8. PubMed ID: 20227498
    [Abstract] [Full Text] [Related]

  • 19. The synthetic triterpenoid CDDO-imidazolide induces monocytic differentiation by activating the Smad and ERK signaling pathways in HL60 leukemia cells.
    Ji Y, Lee HJ, Goodman C, Uskokovic M, Liby K, Sporn M, Suh N.
    Mol Cancer Ther; 2006 Jun 01; 5(6):1452-8. PubMed ID: 16818503
    [Abstract] [Full Text] [Related]

  • 20. Appearance of the arachidonic acid metabolic pathway in human promyelocytic leukemia (HL-60) cells during monocytic differentiation: enhancement of thromboxane synthesis by 1 alpha,25-dihydroxyvitamin D-3.
    Honda A, Morita I, Murota S, Mori Y.
    Biochim Biophys Acta; 1986 Jul 18; 877(3):423-32. PubMed ID: 3089289
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.